113 related articles for article (PubMed ID: 31431542)
1. Reverse signaling by semaphorin 4C elicits SMAD1/5- and ID1/3-dependent invasive reprogramming in cancer cells.
Gurrapu S; Franzolin G; Fard D; Accardo M; Medico E; Sarotto I; Sapino A; Isella C; Tamagnone L
Sci Signal; 2019 Aug; 12(595):. PubMed ID: 31431542
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
[TBL] [Abstract][Full Text] [Related]
3. Sema4C/PlexinB2 signaling controls breast cancer cell growth, hormonal dependence and tumorigenic potential.
Gurrapu S; Pupo E; Franzolin G; Lanzetti L; Tamagnone L
Cell Death Differ; 2018 Jul; 25(7):1259-1275. PubMed ID: 29555978
[TBL] [Abstract][Full Text] [Related]
4. BMP-6 inhibits human bone marrow B lymphopoiesis--upregulation of Id1 and Id3.
Kersten C; Dosen G; Myklebust JH; Sivertsen EA; Hystad ME; Smeland EB; Rian E
Exp Hematol; 2006 Jan; 34(1):72-81. PubMed ID: 16413393
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin 4C Promotes Macrophage Recruitment and Angiogenesis in Breast Cancer.
Yang J; Zeng Z; Qiao L; Jiang X; Ma J; Wang J; Ye S; Ma Q; Wei J; Wu M; Huang X; Ma D; Gao Q
Mol Cancer Res; 2019 Oct; 17(10):2015-2028. PubMed ID: 31308149
[TBL] [Abstract][Full Text] [Related]
7. p53 regulates neural stem cell proliferation and differentiation via BMP-Smad1 signaling and Id1.
Liu H; Jia D; Li A; Chau J; He D; Ruan X; Liu F; Li J; He L; Li B
Stem Cells Dev; 2013 Mar; 22(6):913-27. PubMed ID: 23199293
[TBL] [Abstract][Full Text] [Related]
8. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C.
Li J; Wang Q; Wen R; Liang J; Zhong X; Yang W; Su D; Tang J
J Cell Mol Med; 2015 Dec; 19(12):2793-805. PubMed ID: 26283050
[TBL] [Abstract][Full Text] [Related]
9. Targeting Id1 and Id3 by a specific peptide aptamer induces E-box promoter activity, cell cycle arrest, and apoptosis in breast cancer cells.
Mern DS; Hoppe-Seyler K; Hoppe-Seyler F; Hasskarl J; Burwinkel B
Breast Cancer Res Treat; 2010 Dec; 124(3):623-33. PubMed ID: 20191379
[TBL] [Abstract][Full Text] [Related]
10. Semaphorin 4C and 4G are ligands of Plexin-B2 required in cerebellar development.
Maier V; Jolicoeur C; Rayburn H; Takegahara N; Kumanogoh A; Kikutani H; Tessier-Lavigne M; Wurst W; Friedel RH
Mol Cell Neurosci; 2011 Feb; 46(2):419-31. PubMed ID: 21122816
[TBL] [Abstract][Full Text] [Related]
11. Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells.
Li J; Ye L; Kynaston HG; Jiang WG
Int J Oncol; 2012 Feb; 40(2):544-50. PubMed ID: 22076499
[TBL] [Abstract][Full Text] [Related]
12. Mutations in bone morphogenetic protein type II receptor cause dysregulation of Id gene expression in pulmonary artery smooth muscle cells: implications for familial pulmonary arterial hypertension.
Yang J; Davies RJ; Southwood M; Long L; Yang X; Sobolewski A; Upton PD; Trembath RC; Morrell NW
Circ Res; 2008 May; 102(10):1212-21. PubMed ID: 18436795
[TBL] [Abstract][Full Text] [Related]
13. Semaphorins as Regulators of Phenotypic Plasticity and Functional Reprogramming of Cancer Cells.
Gurrapu S; Tamagnone L
Trends Mol Med; 2019 Apr; 25(4):303-314. PubMed ID: 30824197
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase Cα signaling regulates inhibitor of DNA binding 1 in the intestinal epithelium.
Hao F; Pysz MA; Curry KJ; Haas KN; Seedhouse SJ; Black AR; Black JD
J Biol Chem; 2011 May; 286(20):18104-17. PubMed ID: 21454537
[TBL] [Abstract][Full Text] [Related]
15. Investigating bone morphogenetic protein (BMP) signaling in a newly established human cell line expressing BMP receptor type II.
Kudo TA; Kanetaka H; Watanabe A; Okumoto A; Asano M; Zhang Y; Zhao F; Kano M; Shimizu Y; Tamura S; Hayashi H
Tohoku J Exp Med; 2010 Oct; 222(2):121-9. PubMed ID: 20919447
[TBL] [Abstract][Full Text] [Related]
16. Semaphorin 4A, 4C, and 4D: Function comparison in the autoimmunity, allergy, and cancer.
Rajabinejad M; Asadi G; Ranjbar S; Afshar Hezarkhani L; Salari F; Gorgin Karaji A; Rezaiemanesh A
Gene; 2020 Jul; 746():144637. PubMed ID: 32244055
[TBL] [Abstract][Full Text] [Related]
17. Id1/Id3 knockdown inhibits metastatic potential of pancreatic cancer.
Shuno Y; Tsuno NH; Okaji Y; Tsuchiya T; Sakurai D; Nishikawa T; Yoshikawa N; Sasaki K; Hongo K; Tsurita G; Sunami E; Kitayama J; Tokunaga K; Takahashi K; Nagawa H
J Surg Res; 2010 Jun; 161(1):76-82. PubMed ID: 19515385
[TBL] [Abstract][Full Text] [Related]
18. SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis.
Smeester BA; Slipek NJ; Pomeroy EJ; Bomberger HE; Shamsan GA; Peterson JJ; Crosby MR; Draper GM; Becklin KL; Rahrmann EP; McCarthy JB; Odde DJ; Wood DK; Largaespada DA; Moriarity BS
Oncogene; 2020 Jan; 39(5):1049-1062. PubMed ID: 31582836
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin 4C regulates ovarian steroidogenesis through RHOA/ROCK1-mediated actin cytoskeleton rearrangement.
Chen D; Wu C; Wei S; Guo Y; Wu M; Zhou S; Fu F; Tang W; Xue L; Zhang J; Li Y; Dai J; Li Y; Ye S; Wang S
Mol Hum Reprod; 2023 Apr; 29(5):. PubMed ID: 36892447
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of semaphorin 4 C interferes with the neuroprotective effect of the semaphorin 4 C/Plexin B2 pathway on experimental intracerebral hemorrhage in rats.
Li D; Li X; Wang J; Li H; Shen H; Xu X; Chen G
J Chem Neuroanat; 2023 Oct; 132():102318. PubMed ID: 37482144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
